Beam Therapeutics (BEAM)
Beam Therapeutics (BEAM) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- BEAM last traded at $21.66 on 2026-11-20, 3.46% for the session.
- Beam Therapeutics: market cap $2.24B, revenue $146.64M over the last four quarters.
- Over the past year BEAM returned 3.26%, with a year-to-date return of -21.85%.